BIO CEO: 美国生物技术需紧急制定协调计划应对中国挑战
Opinion: STAT+: BIO CEO: American biotech needs a coordinated plan to beat China — now
美国生物技术创新组织(BIO)CEO 克罗瓦利表示,中国将生物技术列为国家“支柱产业”,旨在超越美国成为全球生物技术领导者。这威胁到美国在生物技术领域的竞争优势,需要紧急制定协调计划来保护和加强美国的生物技术生态系统。
By John F. Crowley
Nov. 10, 2026
Crowley is the president and CEO of the Biotechnology Innovation Organization (BIO).
China just announced a new five-year plan that designates biotechnology as a national “pillar industry” and aims to displace the United States as the world’s biotech leader. Those ambitions threaten one of America’s defining competitive advantages — and they demand an urgent response.
America’s biotech sector supports nearly 10 million jobs and over $3 trillion in annual economic activity. It fuels advanced manufacturing growth, ensures our loved ones have access to the newest and most groundbreaking medicines, and strengthens our defenses against pandemics and biological threats. Losing our biotech lead would mean losing a pillar of both our economy and our national security.
Yet biotech innovation also depends on numerous interconnected players — from the university laboratories and startups that often pioneer new research to the trial networks and manufacturing facilities that bring medicines to patients. That means there’s no single policy that will protect our lead. Instead, we need a plan that strengthens every facet of our biotech ecosystem.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源:STAT 主站 · statnews.com